Vasamed, Inc.

OTCPK:VSMD Stock Report

Market Cap: US$8.0

Vasamed Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Mike Schreiber

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownershipn/a
Management average tenure8yrs
Board average tenure25.4yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Mike Schreiber

8yrs

Tenure

Mr. Michael Schreiber, also known as Mike, has been Chief Executive Officer and President at VASAMED, Inc. since December 8, 2016. Mr. Schreiber has more than 20 years of experience in the medical device a...

Leadership Team

NamePositionTenureCompensationOwnership
Paulita LaPlante
VP & Director8yrsUS$180.00kno data
Michael Schreiber
President & CEO8yrsno datano data
Roberta Dircks
Chief Financial Officer and Vice President of Finance & Administration18.5yrsno datano data
Daniel Bartnik
CTO & VP of Operationsno datano datano data

8.0yrs

Average Tenure

Experienced Management: VSMD's management team is seasoned and experienced (8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paulita LaPlante
VP & Director26.3yrsUS$180.00kno data
Richard Egen
Independent Director27.5yrsno datano data
Charles Snead
Independent Director24.5yrsno datano data
Craig Walker
Director16.4yrsno datano data

25.4yrs

Average Tenure

78yo

Average Age

Experienced Board: VSMD's board of directors are seasoned and experienced ( 25.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 14:33
End of Day Share Price 2024/10/29 00:00
Earnings2009/06/30
Annual Earnings2008/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vasamed, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution